NYSE:ITGR - Integer Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $99.33
  • Forecasted Upside: 8.67 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$91.41
▼ -1.01 (-1.09%)
1 month | 3 months | 12 months
Get New Integer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ITGR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ITGR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$99.33
▲ +8.67% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Integer in the last 3 months. The average price target is $99.33, with a high forecast of $108.00 and a low forecast of $85.00. The average price target represents a 8.67% upside from the last price of $91.41.
Buy
The current consensus among 4 investment analysts is to buy stock in Integer. This rating has held steady since February 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/8/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/7/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/6/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/4/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/2/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/30/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/1/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/30/2020KeyCorpLower Price TargetOverweight$87.00 ➝ $85.00High
i
10/7/2020ArgusDowngradeBuy ➝ HoldHigh
i
5/14/2020BenchmarkInitiated CoverageBuy$105.00Low
i
5/8/2020SidotiBoost Price TargetBuy$100.00 ➝ $108.00High
i
5/8/2020KeyCorpLower Price TargetOverweight$90.00 ➝ $87.00High
i
4/13/2020KeyCorpLower Price TargetOverweight$116.00 ➝ $90.00High
i
2/21/2020KeyCorpBoost Price TargetOverweight$97.00 ➝ $116.00Medium
i
8/2/2019Northcoast ResearchReiterated RatingBuyHigh
i
Rating by D. Keiser at Northcoast Research
6/5/2019ArgusLower Price TargetBuy ➝ Average$90.00 ➝ $4.29Low
i
2/25/2019Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$84.00 ➝ $92.00Low
i
11/2/2018Royal Bank of CanadaBoost Price Target$84.00Low
i
11/2/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$81.00 ➝ $93.00Low
i
8/3/2018Royal Bank of CanadaReiterated RatingHold$72.00High
i
7/20/2018Northcoast ResearchUpgradeBuy$83.00Low
i
Rating by D. Keiser at Northcoast Research
7/13/2018Northcoast ResearchUpgradeNeutral ➝ BuyMedium
i
Rating by D. Keiser at Northcoast Research
7/6/2018KeyCorpReiterated RatingOverweight ➝ Overweight$65.00 ➝ $78.00Medium
i
6/27/2018ArgusInitiated CoverageBuy$78.00Medium
i
5/4/2018KeyCorpBoost Price TargetOverweight ➝ Overweight$60.00 ➝ $62.00Low
i
10/27/2017Royal Bank of CanadaReiterated RatingHold ➝ NeutralN/A
i
10/23/2017Northcoast ResearchDowngradeBuy ➝ NeutralN/A
i
Rating by D. Keiser at Northcoast Research
9/22/2017Royal Bank of CanadaReiterated RatingHold$40.00Low
i
9/18/2017KeyCorpReiterated RatingOverweight$51.00 ➝ $62.00High
i
4/21/2017Royal Bank of CanadaReiterated RatingHold$35.00Low
i
4/19/2017Craig HallumDowngradeBuy ➝ HoldHigh
i
5/16/2016Sterne Agee CRTReiterated RatingBuyN/A
i
Rating by G. Chodaczek at Sterne Agee CRT
3/11/2016KeyCorpReiterated RatingOverweight$59.00 ➝ $51.00N/A
i
(Data available from 3/2/2016 forward)
Integer logo
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac and neuromodulation products, such as batteries, capacitors, filtered feedthroughs, and implantable leads; implanted medical devices, pacemakers, implantable cardioverter defibrillators, implantable cardiac pacing and defibrillation leads, and heart failure therapies, such as ventricular assist devices and cardiac resynchronization devices. In addition, the company offers rechargeable batteries and chargers, and non-rechargeable batteries; arthroscopic devices and components, including shaver blades and burrs, ablation probes, and suture anchors; and laparoscopic and general surgery products, such as harmonic scalpels, radio frequency probes, and ophthalmic surgery devices. Further, it provides orthopedic products, including hip and shoulder joint reconstruction implants, plates, screws, and spinal devices, as well as instruments and delivery systems used in hip and knee replacement, trauma fixation, extremity, and spine surgeries. Additionally, the company offers customized battery power and management systems, charging and docking stations, and power supplies for the energy, military, and environmental markets. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
Read More

Today's Range

Now: $91.41
$91.41
$93.75

50 Day Range

MA: $80.27
$73.80
$88.19

52 Week Range

Now: $91.41
$46.01
$92.52

Volume

6,237 shs

Average Volume

175,903 shs

Market Capitalization

$3.01 billion

P/E Ratio

41.55

Dividend Yield

N/A

Beta

1.42

Frequently Asked Questions

What sell-side analysts currently cover shares of Integer?

The following Wall Street research analysts have issued research reports on Integer in the last year: Argus, Benchmark Co., KeyCorp, Sidoti, and TheStreet.
View the latest analyst ratings for ITGR.

What is the current price target for Integer?

3 Wall Street analysts have set twelve-month price targets for Integer in the last year. Their average twelve-month price target is $99.33, suggesting a possible upside of 8.7%. Sidoti has the highest price target set, predicting ITGR will reach $108.00 in the next twelve months. KeyCorp has the lowest price target set, forecasting a price of $85.00 for Integer in the next year.
View the latest price targets for ITGR.

What is the current consensus analyst rating for Integer?

Integer currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ITGR will outperform the market and that investors should add to their positions of Integer.
View the latest ratings for ITGR.

What other companies compete with Integer?

How do I contact Integer's investor relations team?

Integer's physical mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The medical equipment provider's listed phone number is 214-618-5243 and its investor relations email address is [email protected] The official website for Integer is www.integer.net.